Inducible gene expression of moricin, a unique antibacterial peptide from the silkworm (Bombyx mori).
Molecular cloning of cDNAs encoding moricin, a novel antibacterial peptide from the silkworm (Bombyx mori), was performed using a fat-body cDNA library. A reverse-transcription PCR product encoding a partial nucleotide sequence of moricin was used as a probe. Nucleotide sequencing of four positive clones revealed two types of moricin cDNAs designated moricin 1 and 2. cDNAs for moricin 1 and 2 shared 97.2% identity in their nucleotide sequences. Although one amino acid residue (Phe6) of moricin 1 in the putative signal peptide was replaced with Lys6 in moricin 2, amino acid sequences of their mature portions were identical. Moricin gene expression in B. mori larvae injected with Escherichia coli was observed in fat-bodies, haemocytes and the Malpighian tubule, but not in other tissues like the midgut and silk glands. Accumulation of moricin gene transcripts induced by E. coli reached a maximum level 8 h after injection and persisted up to 48 h. It was confirmed that lipopolysaccharide (LPS) and lipid A, which are cell-wall components of E. coli, triggered moricin gene expression. Comparison of gene expression between moricin 1 and 2 by PCR using specific primers indicated that moricin 2 gene was more strongly expressed than moricin 1 gene. A genomic clone encoding moricin 2 was screened from a B. mori genomic library using a moricin cDNA as a probe. Regulatory motifs for gene expression such as nuclear-factor-kappaB-binding-site-like sequence (kappaB site) and nuclear-factor-interleukin-6-binding-site-like sequence (NF-IL-6 site) were found in the 5'-upstream regulatory region. An electrophoretic-mobility-shift assay revealed that there are bacterial LPS-inducible nuclear proteins that can bind to the kappaB site and other sites in the regulatory region.
Furukawa
S
S
Laboratory of Applied Zoology, Institute of Agriculture and Forestry, University of Tsukuba, Tsukuba, Ibaraki 305-8572, Japan.
Tanaka
H
H
Nakazawa
H
H
Ishibashi
J
J
Shono
T
T
Yamakawa
M
M
D000595:Amino Acid Sequence; D000818:Animals; D000900:Anti-Bacterial Agents / Q000276:immunology; D023181:Antimicrobial Cationic Peptides; D001483:Base Sequence; D001667:Binding, Competitive; D012831:Bombyx / Q000196:embryology / Q000235:genetics* / Q000276:immunology / Q000382:microbiology; D003001:Cloning, Molecular; D017124:Conserved Sequence / Q000235:genetics; D015342:DNA Probes; D018076:DNA, Complementary / Q000235:genetics; D004926:Escherichia coli / Q000276:immunology; D005216:Fat Body / Q000276:immunology / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects; D019476:Insect Proteins; D007814:Larva / Q000235:genetics / Q000276:immunology / Q000382:microbiology; D008050:Lipid A / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008969:Molecular Sequence Data; D009687:Nuclear Proteins / Q000378:metabolism; D009928:Organ Specificity; D010455:Peptides / Q000235:genetics*; D020218:Response Elements / Q000235:genetics
D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D015342:DNA Probes; D018076:DNA, Complementary; D019476:Insect Proteins; D008050:Lipid A; D008070:Lipopolysaccharides; D009687:Nuclear Proteins; D010455:Peptides; C097209:moricin protein, Bombyx mori